Antimycobacterial activity of 1-deaza-7,8-dihydropteridine derivatives against Mycobacterium tuberculosis and Mycobacterium avium complex in vitro.

Twenty-five 1-deaza-7,8-dihydropteridine derivatives were screened for antimycobacterial activity against Mycobacterium tuberculosis strain H37Ra and three Mycobacterium avium clinical isolates (serovar 1, 4 or 6). Antibacterial activity was determined with a colorimetric microdilution broth assay. Seventeen of the compounds inhibited growth in the range >1.28 to <or=12.8 mg/L against one or more of the test strains. The presence of an alkoxycarbonyl group on the amino nitrogen at position 2 was not required for activity. Activity was dependent upon the type and location of group substitutions on the 6-phenyl ring and, in some cases, the presence of a 7-alkyl group.

[1]  Robert C. Reynolds,et al.  Antimycobacterial Activities of 2,4-Diamino-5-Deazapteridine Derivatives and Effects on Mycobacterial Dihydrofolate Reductase , 2000, Antimicrobial Agents and Chemotherapy.

[2]  R. Reynolds,et al.  Slow Polymerization of Mycobacterium tuberculosis FtsZ , 2000, Journal of bacteriology.

[3]  L. Amos,et al.  Crystal structure of the bacterial cell-division protein FtsZ , 1998, Nature.

[4]  D. Snider,et al.  The neglected global tuberculosis problem: a report of the 1992 World Congress on Tuberculosis. , 1994, The Journal of infectious diseases.

[5]  J. Ellner,et al.  Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. , 1991, The Journal of infectious diseases.

[6]  W. Waud,et al.  Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis. , 1987, Cancer research.

[7]  J. Montgomery,et al.  1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships. , 1983, Journal of Medicinal Chemistry.

[8]  D. J. Adamson,et al.  Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3-[(N-methylanilino)methyl]-pyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 181928). , 1982, Cancer research.

[9]  G. P. Wheeler,et al.  1-Deaza-7,8-dihydropteridines, a new class of mitotic inhibitors with anticancer activity. , 1981, Biochemical pharmacology.

[10]  J. Morrison,et al.  The inhibition of dihydrofolate reductase by folate analogues: structural requirements for slow- and tight-binding inhibition. , 1980, Biochemical pharmacology.